Table 3 Mutually-adjusted odds ratios for Helicobacter pylori eradication in 2005 in Taiwan

Age

Every 1-year increment

1.014 (1.012, 1.015)

1.008 (1.005, 1.011)

Sex

Men vs. Women

1.220 (1.171, 1.270)

1.155 (1.071, 1.247)

Diabetes

Yes vs. No

1.133 (1.074, 1.195)

--

Panendoscope examination (1997-2005)

Yes vs. No

8.940 (8.573, 9.321)

5.592 (5.173, 6.045)

Hypertension

Yes vs. No

1.199 (1.129, 1.273)

1.215 (1.098, 1.345)

Chronic obstructive pulmonary disease

Yes vs. No

1.257 (1.202, 1.314)

1.214 (1.121, 1.313)

Stroke

Yes vs. No

1.119 (1.051, 1.191)

1.096 (1.000, 1.201)

Nephropathy

Yes vs. No

1.268 (1.193, 1.347)

1.314 (1.203, 1.435)

Ischemic heart disease

Yes vs. No

1.246 (1.179, 1.317)

1.183 (1.086, 1.289)

Peripheral arterial disease

Yes vs. No

1.126 (1.048, 1.211)

1.133 (1.025, 1.252)

Eye disease

Yes vs. No

0.937 (0.833, 1.053)

0.898 (0.784, 1.029)

Obesity

Yes vs. No

0.971 (0.816, 1.155)

0.815 (0.627, 1.061)

Dyslipidemia

Yes vs. No

1.174 (1.110, 1.242)

1.034 (0.948, 1.127)

Statin

Yes vs. No

1.013 (0.946, 1.086)

1.015 (0.923, 1.116)

Fibrate

Yes vs. No

1.015 (0.944, 1.091)

1.007 (0.913, 1.110)

Angiotensin-converting enzyme inhibitor/ Angiotensin receptor blocker

Yes vs. No

1.011 (0.912, 1.121)

1.051 (0.913, 1.211)

Calcium channel blocker

Yes vs. No

1.147 (1.074, 1.225)

1.108 (1.004, 1.224)

Living region

Northern vs. Taipei

1.103 (1.042, 1.168)

1.082 (0.968, 1.208)

Central vs. Taipei

1.124 (1.056, 1.195)

1.140 (1.022, 1.271)

Southern vs. Taipei

1.027 (0.969, 1.088)

1.047 (0.941, 1.165)

Kao-Ping/Eastern vs. Taipei

0.988 (0.924, 1.058)

0.979 (0.859, 1.116)

Occupation

II vs. I

1.022 (0.961, 1.087)

1.023 (0.910, 1.148)

III vs. I

1.317 (1.235, 1.404)

1.286 (1.144, 1.445)

IV vs. I

1.308 (1.235, 1.386)

1.205 (1.080, 1.345)

Sulfonylurea

Yes vs. No

-

0.978 (0.875, 1.093)

Metformin

Yes vs. No

-

0.972 (0.867, 1.091)

Insulin

Yes vs. No

-

1.414 (1.228, 1.629)

Acarbose

Yes vs. No

-

1.004 (0.863, 1.167)

Pioglitazone

Yes vs. No

-

0.999 (0.787, 1.269)

Rosiglitazone

Yes vs. No

-

0.939 (0.800, 1.101)